内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Apollomics Inc.

APLM · Nasdaq · CIK 0001944885 · Healthcare · Biotechnology

内部人信号

70.0 / 100

3 位买方 · 5 条买入交易行 · $8.3M 买入总额

为什么有这个信号？

买方广度中等
买入规模较强
角色中等
近期性较低
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+21.0 / 35
买入规模+22.6 / 25
角色+13.0 / 20
近期性+3.4 / 10
确信度+10.0 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
  • ⚠ 角色得分低 · 买入者中职位最高的是：Chief Executive Officer（CEO、董事长和持股 10% 以上的股东得分最低）
  • ⚠ Purchase activity is becoming less recent

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
LIN PETER KUAN-HOWChief Financial Officer
○○●○○○○
Chen Yi-KueiChief Operating Officer
○●○○
Chen Hung-WenChief Executive Officer
○●○
CHEN HONG-JUNGDirector
○○
TSAI HSIEN-SHUDirector
○○
Huang Ya-ChiDirector
○○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.

买方广度与集中度

合资格买方3
买入集中度92%最大买方： Chen Hung-Wen · $7.6M
聚集买入 · 15天3 insiders峰值活动： 2026-08-14–2026-08-14

Roles in the peak window: Chief Executive Officer, Chief Financial Officer, Chief Operating Officer. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

70.0 / 100

最新留档分数

↓ -0.2 pts相对上一个留档快照
  1. 70.4
  2. 70.3
  3. 70.2
  4. 70.2
  5. 70.0

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

5买入
0卖出
21其他 Form 4 交易行
21SEC 申报 · 365天
买入5 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他21 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-9.9%
3M
+51.3%
6M
+58.1%
12M
+16.6%

波动率与流动性

波动率
157.6%
Beta
—
平均每日成交额
USD 427,099

估值

市值
USD 47.2M
P/E
—

基本面

利润率
—
ROE
—
细分行业
Biotechnology

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-04-24 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
5,730
上期报告
5,641
日均成交量
9,604
回补天数
≤ 1.0

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-08-14LIN PETER KUAN-HOW买入 (P)CLASS A ORDINARY SHARES26,667USD 15.00USD 400,005SEC 申报 ↗
2026-08-14Chen Yi-Kuei买入 (P)CLASS A ORDINARY SHARES20,000USD 15.00USD 300,000SEC 申报 ↗
2026-08-14Chen Hung-Wen买入 (P)CLASS A ORDINARY SHARES536,667USD 14.07USD 7,550,004SEC 申报 ↗

Form 4 申报证据

26 transaction lines in the latest 365-day window; 26 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-15Yen Hung Hsien期权行权／转换 (M)CLASS A ORDINARY SHARES500USD 0.00USD 0SEC 申报 ↗
2026-09-15LIN PETER KUAN-HOW期权行权／转换 (M)CLASS A ORDINARY SHARES10,000USD 0.00USD 0SEC 申报 ↗
2026-09-15LIN PETER KUAN-HOW代扣税 (F)CLASS A ORDINARY SHARES3,416USD 24.02USD 82,052SEC 申报 ↗
展开近期 Form 4 证据 (24 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-15Yen Hung Hsien期权行权／转换 (M)CLASS A ORDINARY SHARES500USD 0.00USD 0SEC 申报 ↗
2026-09-15LIN PETER KUAN-HOW期权行权／转换 (M)CLASS A ORDINARY SHARES10,000USD 0.00USD 0SEC 申报 ↗
2026-09-15LIN PETER KUAN-HOW代扣税 (F)CLASS A ORDINARY SHARES3,416USD 24.02USD 82,052SEC 申报 ↗
2026-09-15Chen Yi-Kuei期权行权／转换 (M)CLASS A ORDINARY SHARES5,000USD 0.00USD 0SEC 申报 ↗
2026-09-15Yen Hung Hsien期权行权／转换 (M)CLASS A ORDINARY SHARES500USD 0.00USD 0SEC 申报 ↗
2026-09-15TSAI HSIEN-SHU期权行权／转换 (M)CLASS A ORDINARY SHARES500USD 0.00USD 0SEC 申报 ↗
2026-09-15LIN PETER KUAN-HOW期权行权／转换 (M)CLASS A ORDINARY SHARES10,000USD 0.00USD 0SEC 申报 ↗
2026-09-15LIN PETER KUAN-HOW代扣税 (F)CLASS A ORDINARY SHARES3,416USD 24.02USD 82,052SEC 申报 ↗
2026-09-15Chen Yi-Kuei期权行权／转换 (M)CLASS A ORDINARY SHARES5,000USD 0.00USD 0SEC 申报 ↗
2026-09-15Chen Hung-Wen期权行权／转换 (M)CLASS A ORDINARY SHARES5,000USD 0.00USD 0SEC 申报 ↗
2026-09-15CHEN HONG-JUNG期权行权／转换 (M)CLASS A ORDINARY SHARES500USD 0.00USD 0SEC 申报 ↗
2026-08-17Huang Ya-Chi期权行权／转换 (M)CLASS A ORDINARY SHARES500USD 0.00USD 0SEC 申报 ↗
2026-08-14LIN PETER KUAN-HOW买入 (P)CLASS A ORDINARY SHARES26,667USD 15.00USD 400,005SEC 申报 ↗
2026-08-14Chen Yi-Kuei买入 (P)CLASS A ORDINARY SHARES20,000USD 15.00USD 300,000SEC 申报 ↗
2026-08-14Chen Hung-Wen买入 (P)CLASS A ORDINARY SHARES536,667USD 14.07USD 7,550,004SEC 申报 ↗
2026-06-15LIN PETER KUAN-HOW期权行权／转换 (M)CLASS A ORDINARY SHARES10,000USD 0.00USD 0SEC 申报 ↗
2026-06-15LIN PETER KUAN-HOW代扣税 (F)CLASS A ORDINARY SHARES3,588USD 13.85USD 49,694SEC 申报 ↗
2026-06-15TSAI HSIEN-SHU期权行权／转换 (M)CLASS A ORDINARY SHARES500USD 0.00USD 0SEC 申报 ↗
2026-06-15Jan Chen-Huan期权行权／转换 (M)CLASS A ORDINARY SHARES500USD 0.00USD 0SEC 申报 ↗
2026-06-15Chen Yi-Kuei期权行权／转换 (M)CLASS A ORDINARY SHARES5,000USD 0.00USD 0SEC 申报 ↗
2026-06-15Chen Hung-Wen期权行权／转换 (M)CLASS A ORDINARY SHARES5,000USD 0.00USD 0SEC 申报 ↗
2026-06-15CHU YI-AN期权行权／转换 (M)CLASS A ORDINARY SHARES500USD 0.00USD 0SEC 申报 ↗
2026-06-15CHEN HONG-JUNG期权行权／转换 (M)CLASS A ORDINARY SHARES500USD 0.00USD 0SEC 申报 ↗
2026-05-17Huang Ya-Chi期权行权／转换 (M)CLASS A ORDINARY SHARES500USD 0.00USD 0SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码APLM
CIK0001944885
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史26 transaction lines from 2026-05-17 to 2026-09-15
5 P purchase lines · 0 S sale lines · 21 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.